大麻对大脑和身体的影响

大麻（Marijuana）：对大脑和身体的影响

摘要

本期节目从科学角度全面介绍了大麻中的化合物——主要是THC和CBD——如何通过内源性大麻素系统与大脑和身体相互作用。Andrew Huberman探讨了不同大麻品系及其各异的效果、作用机制，以及决定大麻对某一特定个体是有益还是有害的各种变量。核心话题包括创造力、记忆力、食欲、焦虑、激素，以及年龄和遗传易感性的关键重要性。

---

核心要点

• 大麻含有超过70种精神活性化合物，以及超过400种具有生物活性的化合物；目前大多数研究仅聚焦于THC和CBD。
• THC与大麻素受体的结合效力比人体自身内源性大麻素高出1,000倍，实际上会关闭内源性大麻素系统。
• 品系类型和THC:CBD比例（1型、2型或3型）对效果有强烈的预测作用——但个体反应仍高度不可预测。
• Sativa品种倾向于产生类兴奋剂的、以头部为中心的效果（专注、情绪提升、话多）；indica品种倾向于产生全身镇静和放松效果。
• 目前没有可靠方法预测某人使用大麻后会体验到放松还是偏执——性格或基线焦虑水平并不是有效的预测指标。
• 记忆损害（尤其是短期记忆）在几乎所有大麻使用中都会发生，无论何种品系，原因是海马体活动受到抑制。
• THC和CBD在脂肪组织中的可检测时间最长可达80天。
• 大麻摄入后30–60分钟达到峰值效果，平均持续3–4小时。
• CB1受体（神经系统）驱动大多数精神活性效果；CB2受体（免疫系统、肝脏、生殖器官）驱动外周效应，包括免疫调节。
• 依赖性的产生是因为长期使用大麻会超越内源性大麻素的竞争能力，导致不使用时出现焦虑、情绪紊乱和睡眠问题。

---

详细笔记

大麻品系与种类

• Sativa：植株高大，叶片细长；倾向于产生类兴奋剂的”头部亢奋”效果——情绪提升、警觉、话多、注意力集中、轻度镇痛。
• Indica：植株矮小粗壮；倾向于产生全身放松、镇静效果，减少失眠、抑制焦虑。常被记忆为”沉入沙发（in-da-couch）”。
• Ruderalis：第三种品种，极少用于医疗或娱乐用途。
• 杂交品系：Sativa与indica以不同比例杂交（如25/75、50/50），越来越多地被设计用于产生特定的、细腻的效果。

1型、2型和3型分类（THC:CBD比例）

类型	THC	CBD	效果倾向
1型	高	低	最强精神活性效果
2型	相等	相等	中等/平衡
3型	低	高	精神活性最小；更偏向身体效果

• 该分类适用于sativa、indica和杂交品系。
• 理解这一比例对于预测效果和管理剂量至关重要。

内源性大麻素系统

• 大脑和身体天然产生内源性大麻素：
  • 花生四烯酸乙醇胺（Anandamide，AEA）
  • 2-花生四烯酸甘油（2-Arachidonoylglycerol，2-AG）
• 这些化学物质与**大麻素受体（CB1和CB2）**结合，该受体从受孕起贯穿整个生命周期均存在。
• CB1受体：集中分布于大脑和脊髓；负责大多数精神活性效果。
• CB2受体：存在于免疫组织、肝脏、生殖器官；参与免疫和外周生物学效应。
• 内源性大麻素是逆行信号——由突触后神经元释放，向后传递以调节突触前神经元的活动。
• 根据情境不同，它们既可以**增强（长时程增强）也可以减弱（长时程抑制）**突触通讯。

THC和CBD的作用方式

• THC和CBD与CB1（及CB2）受体的结合亲和力远高于内源性大麻素——类似于合成睾酮与人体自身睾酮的关系。
• 这种效力超越了内源性系统的竞争能力，使其在大麻致醉期间基本失去功能。
• 结果高度依赖于情境：同一分子可以激活某些回路（如前额叶皮质→增强专注力、情绪），同时抑制其他回路（如杏仁核→降低威胁检测/压力反应）。

受影响的脑区

• 海马体：受抑制→短期（以及潜在的长期）记忆损害；在所有品系中普遍存在。
• 前额叶皮质：被sativa激活→注意力集中、情绪提升、通过抑制边缘系统回路减少焦虑；被indica抑制→减少思维/计划，有助于睡眠。
• 杏仁核：通常受抑制→降低威胁检测和应激反应。
• 基底神经节和小脑：受抑制→降低身体活动能力，损害运动规划和平衡感。
• 下丘脑（弓状核）：CB1受体密度高→通过两种机制刺激食欲（“暴食症”）：对食物的认知性专注，以及影响血糖的肠道信号。
• 脊髓CB1受体：在一定程度上有助于镇痛（antinociception）。

起效时间、持续时间和代谢清除

• 起效时间（吸烟/吸入）：THC在30秒内通过肺部血管系统→血液循环→血脑屏障到达大脑。
• 峰值效果：摄入后30–60分钟。
• 持续时间：3–4小时（因代谢、使用经验和使用频率而异）。
• 亲脂性：THC和CBD具有高度脂溶性；可穿透细胞膜并储存在脂肪组织中。
• 检测窗口期：末次使用后在脂肪组织中最长可检测80天。

常见躯体效应（与品系无关）

• 眼睛充血：泪腺分泌减少（眼部CB1/CB2受体）。
• 口干：唾液分泌减少（口腔CB1/CB2受体）。
• 活动能力下降：基底神经节和小脑受抑制。
• 食欲增加：下丘脑CB1激活＋肠道血糖信号。
• 短期记忆损害：海马体受抑制。

焦虑与偏执

• 部分人在使用大麻后会体验到强烈的焦虑和偏执感，即使是原本旨在减少焦虑的sativa品种也不例外。
• 目前不存在可靠的预测指标来判断谁会体验偏执感、谁会体验放松感——基线焦虑水平并非有用的指标。
• “使用更多可以缓解偏执”的说法完全错误。
• 个体反应似乎具有一致性：如果某种品系引起偏执，该品种很可能对该人反复产生同样效果。
• 偏执感很可能源于CB1激活模式的差异——在易感个体中放大了威胁回路，而非抑制它们。

大麻与创造力

• Sativa品种以及对前额叶皮质激活和杏仁核抑制的广泛影响，可能支持感知上的创造力状态。
• 大麻似乎能提高收敛性和发散性思维——这两者是创造性认知的常见组成部分。
• 然而，区分创造力的实际提升与对创造力的感知提升非常重要——两者未必相同。

依赖性与戒断

• 长期使用大麻会抑制内源性大麻素系统。
• 停止使用后，内源性系统无法完全代偿，导致：
  • 焦虑加重
  • 情绪紊乱
  • 睡眠障碍
• 这一机制解释了心理性和生理性依赖是如何形成的。

剂量考量

• 食用型大麻：允许更精确的剂量控制（明确标注THC和CBD的毫克数）。
• 吸烟/蒸发型：难以准确估算THC/CBD的精确剂量。

---

English Original 英文原文

Cannabis (Marijuana): Effects on the Brain & Body

Summary

This episode provides a comprehensive, science-based overview of how cannabis compounds — primarily THC and CBD — interact with the brain and body through the endocannabinoid system. Andrew Huberman explores different cannabis strains, their distinct effects, mechanisms of action, and the variables that determine whether cannabis is beneficial or harmful for a given individual. Key topics include creativity, memory, appetite, anxiety, hormones, and the critical importance of age and genetic predisposition.

---

Key Takeaways

• Cannabis contains over 70 psychoactive compounds and over 400 biologically active compounds; most research has focused only on THC and CBD.
• THC binds cannabinoid receptors with 1,000-fold greater potency than the body’s own endocannabinoids, effectively shutting down the endogenous cannabinoid system.
• Strain type and THC:CBD ratio (Type 1, 2, or 3) strongly predict effects — but individual response is still highly unpredictable.
• Sativa varieties tend to produce stimulant-like, head-centered effects (focus, elevated mood, talkativeness); indica varieties tend to produce full-body sedation and relaxation.
• There is no reliable way to predict whether a person will experience relaxation vs. paranoia from cannabis — personality or baseline anxiety level is not a predictor.
• Memory impairment (especially short-term) occurs with virtually all cannabis use regardless of strain, due to suppressed hippocampal activity.
• THC and CBD remain detectable in fatty tissue for up to 80 days after ingestion.
• Cannabis reaches peak effects within 30–60 minutes of ingestion and effects last 3–4 hours on average.
• CB1 receptors (nervous system) drive most psychoactive effects; CB2 receptors (immune system, liver, genitals) drive peripheral effects including immune modulation.
• Dependence emerges because chronic cannabis use outcompetes endogenous cannabinoids, causing anxiety, mood disruption, and sleep problems when not using.

---

Detailed Notes

Cannabis Strains and Varieties

• Sativa: Tall plant with long leaves; tends to produce stimulant-like, “head high” effects — elevated mood, alertness, talkativeness, narrowed focus, mild pain relief.
• Indica: Short, stout plant; tends to produce full-body relaxation, sedation, reduced insomnia, suppressed anxiety. Often remembered as “in-da-couch.”
• Ruderalis: A third variety, rarely consumed medicinally or recreationally.
• Hybrid strains: Crosses of sativa and indica in various ratios (e.g., 25/75, 50/50), increasingly engineered for specific, nuanced effects.

Type 1, 2, and 3 Classification (THC:CBD Ratio)

Type	THC	CBD	Effect Tendency
Type 1	High	Low	Strongest psychoactive effects
Type 2	Equal	Equal	Moderate/balanced
Type 3	Low	High	Minimal psychoactive; more body-focused

• This classification applies across sativa, indica, and hybrid strains.
• Understanding this ratio is critical for predicting effects and managing dosage.

The Endocannabinoid System

• The brain and body naturally produce endogenous cannabinoids:
  • Anandamide (AEA)
  • 2-Arachidonoylglycerol (2-AG)
• These chemicals bind to cannabinoid receptors (CB1 and CB2), which exist from conception throughout life.
• CB1 receptors: Concentrated throughout the brain and spinal cord; responsible for most psychoactive effects.
• CB2 receptors: Found in immune tissues, liver, reproductive organs; involved in immune and peripheral biological effects.
• Endocannabinoids are retrograde signals — released from postsynaptic neurons and traveling backward to modulate presynaptic neuron activity.
• They can either increase (long-term potentiation) or decrease (long-term depression) synaptic communication depending on context.

How THC and CBD Work

• THC and CBD bind CB1 (and CB2) receptors with vastly greater affinity than endogenous cannabinoids — analogous to synthetic testosterone vs. the body’s own testosterone.
• This potency outcompetes the endogenous system, rendering it essentially non-functional during cannabis intoxication.
• The result is highly context-dependent: the same molecule can activate certain circuits (e.g., prefrontal cortex → increased focus, mood) while suppressing others (e.g., amygdala → reduced threat detection/stress).

Brain Regions Affected

• Hippocampus: Suppressed → short-term (and potentially long-term) memory impairment; universal across all strains.
• Prefrontal cortex: Activated by sativa → narrowed focus, elevated mood, reduced anxiety via brake on limbic circuits. Suppressed by indica → reduced thinking/planning, supports sleep.
• Amygdala: Generally suppressed → reduced threat detection and stress response.
• Basal ganglia & cerebellum: Suppressed → reduced physical mobility, impaired motor planning and balance.
• Hypothalamus (arcuate nucleus): High CB1 density → appetite stimulation (“the munchies”) via two mechanisms: cognitive preoccupation with food AND gut signaling that affects blood sugar.
• Spinal cord CB1 receptors: Contribute to some degree of pain relief (antinociception).

Onset, Duration, and Clearance

• Onset (smoked/inhaled): THC reaches the brain within 30 seconds via lung vasculature → bloodstream → blood-brain barrier.
• Peak effects: 30–60 minutes post-ingestion.
• Duration: 3–4 hours (varies with metabolism, familiarity, and frequency of use).
• Lipophilicity: THC and CBD are highly fat-soluble; they penetrate cell membranes and remain stored in fatty tissues.
• Detection window: Up to 80 days in fatty tissue after last use.

Common Physical Effects (Strain-Independent)

• Red eyes: Reduced lacrimal gland secretion (CB1/CB2 receptors in eyes).
• Dry mouth: Reduced saliva secretion (CB1/CB2 receptors in mouth).
• Reduced mobility: Basal ganglia and cerebellar suppression.
• Increased appetite: Hypothalamic CB1 activation + gut blood sugar signaling.
• Short-term memory impairment: Hippocampal suppression.

Anxiety and Paranoia

• Some individuals experience intense anxiety and paranoia from cannabis, even from sativa varieties intended to reduce anxiety.
• No reliable predictor exists for who will experience paranoia vs. relaxation — baseline anxiety levels are not a useful indicator.
• The idea that “using more will fix paranoia” is categorically false.
• Individual response appears consistent: if a strain causes paranoia, it is likely to do so repeatedly for that person.
• Paranoia likely results from differential CB1 activation patterns — amplifying threat circuits rather than suppressing them in susceptible individuals.

Cannabis and Creativity

• Sativa varieties and the broader effects on prefrontal cortex activation and amygdala suppression may support states of perceived creativity.
• Cannabis appears to increase convergent and divergent thinking — two components commonly associated with creative cognition.
• However, it is important to distinguish actual increases in creativity from perceived increases in creativity — these are not necessarily the same.

Dependence and Withdrawal

• Regular cannabis use suppresses the endogenous cannabinoid system.
• Upon cessation, the endogenous system cannot fully compensate, leading to:
  • Heightened anxiety
  • Disrupted mood
  • Sleep disruption
• This mechanism explains how psychological and biological dependence develops.

Dosing Considerations

• Edibles: Allow more precise dosing (defined milligrams of THC and CBD).
• Smoked/vaped forms: Difficult to gauge exact THC/CBD